InMode (INMD) vs QuidelOrtho (QDEL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
InMode (INMD) has outperformed QuidelOrtho (QDEL) over the past year, losing 6.4% versus a loss of 55.5%. Over five years, INMD leads with a -83.1% price change compared with -90.3% for QDEL. QuidelOrtho is the larger company by market cap ($851.0 million vs $810.2 million), about 1.1 times the size.
On valuation, QuidelOrtho trades at a lower forward P/E (8.6x vs 10.3x for InMode).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | INMD | QDEL |
|---|---|---|
| Share price | $14.08 | $12.41 |
| Market cap | $810.22M | $851.02M |
| 1-day change | +0.50% | +0.81% |
| YTD return | -4.15% | -56.55% |
| 1-year return | -6.45% | -55.46% |
| 5-year return | -83.11% | -90.32% |
| P/E ratio (TTM) | 11.64 | — |
| Forward P/E | 10.26 | 8.61 |
| EPS (TTM) | $1.21 | $-15.39 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $16.67 | $35.58 |
| 52-week low | $12.72 | $9.92 |
| Distance from 52-week high | -15.54% | -65.12% |
| Analyst consensus | none | hold |
| Avg. price target upside | +14.84% | +18.21% |
| Average volume | 501.37K | 1.51M |
| Shares outstanding | 57.54M | 68.58M |
| Employees | 660 | 6,500 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- INMD has outperformed QDEL by 49.0 percentage points over the past year.
About InMode
INMD stock →InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 660 employees
About QuidelOrtho
QDEL stock →QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units.
Health Care · Biotechnology: In Vitro & In Vivo Diagnostic Substances · 6,500 employees
INMD vs QDEL FAQ
Which is bigger, InMode or QuidelOrtho?
QuidelOrtho (QDEL) is larger, with a market capitalization of $851.02M compared with $810.22M for InMode (INMD).
Which stock has performed better over the past year, INMD or QDEL?
INMD returned -6.45% over the past 12 months, compared with -55.46% for QDEL (price return, excluding dividends). Past performance does not predict future results.
Are InMode and QuidelOrtho in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: Electromedical & Electrotherapeutic Apparatus for InMode and Biotechnology: In Vitro & In Vivo Diagnostic Substances for QuidelOrtho.